|
|
Volumn 57, Issue 4, 2001, Pages 4-27
|
|
Executive summary of the National Cancer Institute workshop: Highlights and recommendations
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIANDROGEN;
BIOLOGICAL MARKER;
CAROTENOID;
CELECOXIB;
CYTOTOXIC AGENT;
EFLORNITHINE;
ENDOTHELIN 1;
FENRETINIDE;
FIBROBLAST GROWTH FACTOR RECEPTOR;
FINASTERIDE;
LIPOXYGENASE INHIBITOR;
MATRIX METALLOPROTEINASE INHIBITOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN KINASE INHIBITOR;
PROTEINASE INHIBITOR;
RETINOID;
ROFECOXIB;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SELENIUM;
SULINDAC SULFONE;
VITAMIN D DERIVATIVE;
CANCER INHIBITION;
CANCER INVASION;
CHEMOPROPHYLAXIS;
CONFERENCE PAPER;
DRUG EFFECT;
GENE THERAPY;
GROWTH INHIBITION;
HIGH RISK POPULATION;
HUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
TUMOR GROWTH;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG INDUSTRY;
GOVERNMENT;
HUMANS;
INTERINSTITUTIONAL RELATIONS;
MALE;
MIDDLE AGED;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PRACTICE GUIDELINES;
PROSTATIC NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0034964903
PISSN: 00904295
EISSN: None
Source Type: Journal
DOI: 10.1016/S0090-4295(00)00931-6 Document Type: Article |
|
Times cited : (22)
|
|
References (11)
|
